Pharmacoeconomics: identifying the issues overview and advisory panel report summary.
نویسندگان
چکیده
1 Hoechst Marion Roussel, Inc., Kansas City, MO, 2 International Society for Pharmacoeconomics and Outcomes Research, Princeton, NJ, 3 BioMedCom Consultants inc., Montréal, Canada, 4 The Institute for Research & Education, HealthSystems Minnesota, Minneapolis, MN, 5 Merck Medco Managed Care, LLC, Montvale, NJ, 6 University of Southern California, Los Angeles, CA, 7 Bristol-Myers Squibb, Princeton, NJ, 8 Pharmacon International, New York, NY, 9 Eli Lilly and Company, Indianapolis, IN, 10 Parke-Davis Pharmaceutical Research, Ann Arbor, MI, 11 Stadtlander Drug Company, Inc. and University of Pittsburgh, Pittsburgh, PA, 12 Ingenix, Eden Prairie, MN, 13 Alcon Laboratories, Inc., Fort Worth, TX, 14 Prime Therapeutics, Eagan, MN, 15 SmithKline Beecham, Collegeville, PA, 16 Agency for Health Care Policy and Research, Rockville, MD
منابع مشابه
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
OBJECTIVES A growing number of prospective clinical trials include economic end points. Recognizing the variation in methodology and reporting of these studies, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) chartered the Task Force on Good Research Practices: Randomized Clinical Trials-Cost-Effectiveness Analysis. Its goal was to develop a guidance document for d...
متن کاملSocial Security Technical Panel Report to the 1991 Advisory Council on Social Security: appendices.
The quadrennial Advisory Council on Society Security convened a panel of economists and actuaries to review the economic and demographic assumptions and the methods used to project the status of the Social Security trust funds. In August 1990, the Panel of Technical Experts submitted a report of their findings and recommendations, which were reprinted in the November Social Security Bulletin. I...
متن کاملPanel 6: addressing questions of bias, credibility, and quality in health economic evaluations.
Bias, quality, and credibility are long-term research issues addressed by experts in many fields. Like other disciplines, the field of health economics continues to evolve and challenge itself in this regard. Improvements in this field of research necessitate support and adhesion to the highest quality work and integrity, promotion of continuous quality enhancement, and open dialogue. Definitio...
متن کاملMultiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
Health care decisions are complex and involve confronting trade-offs between multiple, often conflicting objectives. Using structured, explicit approaches to decisions involving multiple criteria can improve the quality of decision making. A set of techniques, known under the collective heading, multiple criteria decision analysis (MCDA), are useful for this purpose. In 2014, ISPOR established ...
متن کاملEntrepreneurial Properties and Tendency of Agricultural Advisory Personnel
The main purpose of this study was to evaluate the influence of entrepreneurial characteristics of members of technical and engineering companies and agricultural advisory services on their willingness toward entrepreneurial activities. Entrepreneurship development plays an important role in job creation process which can eventually lead to the achievement of sustainable development goals in ag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
دوره 2 2 شماره
صفحات -
تاریخ انتشار 1999